Osaic Holdings’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31 Buy
52
+2
+4% +$1 ﹤0.01% 7907
2026
Q1
$25 Hold
50
﹤0.01% 7707
2025
Q4
$28 Sell
50
-160
-76% -$189 ﹤0.01% 7724
2025
Q3
$394 Hold
210
﹤0.01% 7582
2025
Q2
$185 Hold
210
﹤0.01% 7516
2025
Q1
$108 Buy
210
+10
+5% +$6 ﹤0.01% 7230
2024
Q4
$101 Hold
200
﹤0.01% 7243
2024
Q3
$707 Hold
200
﹤0.01% 6937
2024
Q2
$1.6K Hold
200
﹤0.01% 6676
2024
Q1
$2.7K Hold
200
﹤0.01% 6353
2023
Q4
$2.16K Sell
200
-40
-17% -$452 ﹤0.01% 6516
2023
Q3
$1.56K Sell
240
-20
-8% -$246 ﹤0.01% 6708
2023
Q2
$4.68K Sell
260
-24
-8% -$560 ﹤0.01% 6350
2023
Q1
$6.67K Sell
284
-340
-54% -$8.59K ﹤0.01% 6200
2022
Q4
$17K Hold
624
﹤0.01% 5678
2022
Q3
$21K Hold
624
﹤0.01% 5548
2022
Q2
$24K Hold
624
﹤0.01% 5490
2022
Q1
$25K Hold
624
﹤0.01% 5557
2021
Q4
$31K Buy
624
+100
+19% +$5.35K ﹤0.01% 5482
2021
Q3
$34K Buy
524
+80
+18% +$3.45K ﹤0.01% 5399
2021
Q2
$17K Hold
444
﹤0.01% 5752
2021
Q1
$23K Buy
444
+44
+11% +$2.95K ﹤0.01% 5390
2020
Q4
$27K Hold
400
﹤0.01% 4978
2020
Q3
$15K Buy
400
+280
+233% +$11.1K ﹤0.01% 5075
2020
Q2
$5K Hold
120
﹤0.01% 5480
2020
Q1
$4K Buy
+120
New +$7.25K ﹤0.01% 5448

Other funds holding MTNB

Osaic Holdings's MTNB Position: Q2 2026 in Review

Osaic Holdings increased its Matinas BioPharma (MTNB) stake by 4% in Q2 2026, buying an estimated $1 and bringing the position to 52 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #7907.

Osaic Holdings first reported a position in MTNB in Q1 2020 and has held it in 26 quarters since. The position peaked at $34K in Q3 2021. 25 funds tracked by Wall St. Rank hold MTNB as of Q2 2026.

  • Osaic Holdings held 52 shares of Matinas BioPharma worth $31 as of Q2 2026.
  • Osaic Holdings bought 2 Matinas BioPharma shares in Q2 2026, an estimated $1.
  • Matinas BioPharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7907 holding.
  • Osaic Holdings first reported a position in Matinas BioPharma in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Matinas BioPharma position peaked at $34K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.